| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |